NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT06206902 2024-02-23F01 in the Treatment of Relapsed/Refractory Non-hodgkin's LymphomaShanghai Simnova Biotechnology Co.,Ltd.Phase 1 Unknown55 enrolled
NCT03236857 2023-05-22A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesAbbViePhase 1 Completed143 enrolled
NCT02782845 2016-11-21An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)Hoffmann-La RochePhase 4 Completed53 enrolled
NCT00109356 2007-05-07Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic LeukemiaNovaceaPhase 1/2 Unknown55 enrolled